745 related articles for article (PubMed ID: 10738048)
1. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
[TBL] [Abstract][Full Text] [Related]
2. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
3. [Are the newer antihypertensive agents better and more effective than diuretics?].
Landmark K
Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive therapy and the risk of type 2 diabetes mellitus.
Sowers JR; Bakris GL
N Engl J Med; 2000 Mar; 342(13):969-70. PubMed ID: 10738057
[No Abstract] [Full Text] [Related]
5. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
6. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L
Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects.
Mykkänen L; Kuusisto J; Pyörälä K; Laakso M; Haffner SM
J Hypertens; 1994 Dec; 12(12):1425-32. PubMed ID: 7706704
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
[TBL] [Abstract][Full Text] [Related]
10. [Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension].
Nilsson P
Lakartidningen; 2000 Aug; 97(35):3710-2. PubMed ID: 11016222
[No Abstract] [Full Text] [Related]
11. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
12. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
[TBL] [Abstract][Full Text] [Related]
13. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale.
Verdecchia P; Schillaci G; Reboldi G; Borgioni C; Ciucci A; Porcellati C
Diabetes Nutr Metab; 1999 Aug; 12(4):292-9. PubMed ID: 10782756
[TBL] [Abstract][Full Text] [Related]
15. [Revival of antihypertensive therapy: use of thiazide diuretics].
Nagy V
Orv Hetil; 2004 Mar; 145(13):669-76. PubMed ID: 15125317
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medications and risk of diabetes mellitus.
Barzilay JI; Cutler JA; Davis BR
Curr Opin Nephrol Hypertens; 2007 May; 16(3):256-60. PubMed ID: 17420670
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Bangalore S; Parkar S; Grossman E; Messerli FH
Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
[TBL] [Abstract][Full Text] [Related]
19. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]